Cargando…

Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab

BACKGROUND: A significant portion of diabetic macular edema (DME) is refractory to anti-vascular endothelial growth factor (anti-VEGF) agents. This study investigates morphological and functional outcomes to a single intravitreal bevacizumab (IVB) injection in patients with center-involving DME (ciD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turski, Christopher A., Jacobs, Mitchell A., Abou-Jaoude, Michelle M., Fowler, Nicholas H., Harpole, Ryan, Altman, Emily, Chadwell, John B., Kindl, Gabriel, James, Hayley R., Reddy, Shivani V., Maldonado, Ramiro S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673338/ https://www.ncbi.nlm.nih.gov/pubmed/36397121 http://dx.doi.org/10.1186/s40942-022-00430-z

Ejemplares similares

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Resolution of macular edema in Coats' disease with intravitreal bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2010)

Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane
por: Maryam, Ashraf Khorasani, et al.
Publicado: (2018)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon, Sohee, et al.
Publicado: (2014)

Primary Effects of Intravitreal Bevacizumab in Patients with Diabetic Macular Edema
por: Tareen, Iftikhar-ul-Haq, et al.
Publicado: (2013)

Intravitreal Bevacizumab Alone versus Combined with Macular Photocoagulation in Diabetic Macular Edema
por: Lee, Soo Jeong, et al.
Publicado: (2011)

Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema
por: Lee, Yun Ji, et al.
Publicado: (2019)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

Comparison of the Short-Term Effects of Intravitreal Triamcinolone Acetonide and Bevacizumab Injection for Diabetic Macular Edema
por: Song, Ju Hwan, et al.
Publicado: (2011)

Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
por: Yoo, Seul Gi, et al.
Publicado: (2015)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
por: Ghasemi Falavarjani, Khalil, et al.
Publicado: (2012)

Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
por: de ANDRADE, Felipe L., et al.
Publicado: (2016)

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection
por: Ghassemi, Fariba, et al.
Publicado: (2017)

Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome
por: ElBendary, Amal, et al.
Publicado: (2018)

Effect of Intravitreal Bevacizumab with or without Macular Photocoagulation for Diabetic Macular Edema: A Meta-Analysis
por: Xiao, Kang, et al.
Publicado: (2018)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
por: Kumar, Atul, et al.
Publicado: (2007)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy
por: Brito, Isis A. S., et al.
Publicado: (2015)

Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial
por: Fazel, Farhad, et al.
Publicado: (2020)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
por: Das, Gopal K., et al.
Publicado: (2018)

Comparison of Intravitreal Bevacizumab and Intravitreal Diclofenac in the Treatment of Diabetic Macular Edema: a 6-month Follow-up
por: FAGHIHI, Hooshang, et al.
Publicado: (2017)

Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema–Systematic review, meta-analysis and meta-regression
por: Abdel-Maboud, Mohamed, et al.
Publicado: (2021)

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey, Hatem M, et al.
Publicado: (2011)

Resolution of Severe Macular Edema in Adult Coats' Disease with Intravitreal Triamcinolone and Bevacizumab Injection
por: Jun, Jong-Hwa, et al.
Publicado: (2008)

Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous
por: Ozsutcu, Mustafa, et al.
Publicado: (2013)

Intravitreal Injection of Bevacizumab to Treat a Macular Edema Caused by Leber's Miliary Aneurysm
por: Takeyama, Masayuki, et al.
Publicado: (2012)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
por: Joshi, Lavnish, et al.
Publicado: (2016)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
por: Mushtaq, Bushra, et al.
Publicado: (2014)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska, Biljana, et al.
Publicado: (2017)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion
por: Yoo, Su Jin, et al.
Publicado: (2017)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat, Alaa, et al.
Publicado: (2021)

Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
por: Sharma, Ashish, et al.
Publicado: (2012)

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
por: Azad, Rajvardhan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1pobmp2apc7rutaj9hdltnekug